Switzerland’s largest bank is believed to hold shares in the Hikvision group whose products are used to monitor the Uighurs in detention camps and public spaces.
The Chinese state owned firm was blacklisted by the US Department of Commerce in October for its role in the surveillance of ethnic minorities.
According to the SonntagsBlick, UBS was one of Hikvision’s top shareholders for years. In 2016, the bank was listed as the sixth largest shareholder and as of March 2019 it was still the ninth largest. This was despite the fact that it was already public knowledge at the time that Hikvision was significantly involved in the surveillance apparatus against the Uighurs. The bank does not want to comment on the extent of its current investment in Hikvision. In principle, UBS does not comment on individual client relationships.
Switzerland joins calls demanding closure of Uighur camps
This content was published on
Switzerland has called on China to close internment camps in Xinjiang where at least a million ethnic minority Muslims are reportedly being held.
How is your country dealing with the return of stolen artifacts?
Western nations like Switzerland often have to deal with the process of recovering or returning looted artifacts which have been illegally imported. What’s the situation like in your country?
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Sylvain Saudan, ‘skier of the impossible’, dies aged 87
This content was published on
The Swiss father of extreme skiing pioneered descents from the Alps to the Himalayas – and became the sport’s first star.
Hayek family buys additional Swatch shares for nearly CHF11 million
This content was published on
Following the acquisition of registered shares worth over CHF20.6 million on Monday, the Hayek family made another purchase on Tuesday.
Suicide capsule to be used in Switzerland this year, says euthanasia organisation
This content was published on
The organisation “The Last Resort” has confirmed that the suicide capsule Sarco is to be used in Switzerland. This should happen this year, it said.
Ukrainian children flown to Switzerland for cancer treatment
This content was published on
The Swiss air rescue service Rega flew two Ukrainian children with cancer to Switzerland from a hospital in Kyiv hit by Russian missiles.
Swiss Solidarity raises over CHF10 million for victims of extreme weather
This content was published on
The money raised will be used to help those affected by the recent storms and flooding in the cantons of Ticino, Graubünden, and Valais.
Swiss giant Roche given green light for lung cancer drug in Canada
This content was published on
According to a recent study, Roche’s Alecensaro reduced the risk of recurrence or death by 76% compared to chemotherapy alone.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Uighur exile leader calls on Switzerland to curb China ties
This content was published on
“The time for expressions of concern is over,” said Dolkun Isa, the president of the World Uighur Congress, in an interview with swissinfo.ch in Geneva. The exile group says it campaigns for self-determination. Chinese government representatives have previously denounced members of the group as terrorists and criminals. Isa’s visit comes amid growing criticism globally, including…
This content was published on
The Swiss president is in China, where he will sign a memorandum of understanding focusing on finance and trade. What’s in it for both countries?
Swiss president defends controversial Chinese project
This content was published on
Ueli Maurer says it’s important for Switzerland to take part in the Belt and Road summit and bring its own values to the table.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.